Eli Lilly and Company Advocates for Semiannual Reporting Framework to Streamline Disclosure and Reduce Compliance Burden
Eli Lilly and Company, a global pharmaceutical leader with a rich history spanning nearly 150 years, has formally expressed its support for the U.S. Securities and Exchange Commission’s (SEC) proposed…
